Advertisement

Topics

WILEX AG Company Profile

22:34 EST 20th November 2018 | BioPortfolio

WILEX is a biopharmaceutical company developing novel cancer therapies for the treatment of various tumors including renal and breast cancer. Therapies are based upon biologic targets directly connected to cancer progression and pathogenesis in order to provide effective and well-tolerated treatment and enhance patients' quality of life.The company has a portfolio of cancer drug candidates ranging from research to late stage clinical development. The company has two therapeutic platforms: antibodies, which specifically target the tumor cells, and small molecules, which block metastasis and primary tumor growth.
Currently, WILEX has three drug candidates in clinical development. The lead compound Rencarex® (WX-G250), a targeted antibody therapy for the treatment of solid tumors, is currently in a pivotal clinical Phase III trial as an adjuvant treatment of non-metastatic renal cell cancer (RCC). The company’s non-cytotoxic uPA and serine protease inhibitors WX-UK1 and WX-671, which are in clinical development, are assigned for the anti-metastatic treatment of breast cancer and other solid tumors. The company’s pre-clinical research pipeline currently consists of two projects.
WILEX was founded in 1997 by clinical oncologists from the Technical University of Munich.

Location

Grillparzerstr. 16
Munich
81675
Germany

Contact

Phone: 49 (0)89 41 31 38 0
Fax: 49 (0)89 41 31 38 99
Email: investors@wilex.com


News Articles [2 Associated News Articles listed on BioPortfolio]

Telix licenses Wilex’ girentuximab programme

Heidelberg Pharma AG WL6 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 16042018] Prices from USD $250

SummaryHeidelberg Pharma AGHeidelberg Pharma formerly known as Wilex AG is a biopharmaceutical company with a focus on cancer. The company develops therapeutic and diagnostic product candidates for th...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

WILEX AG

WILEX is a biopharmaceutical company developing novel cancer therapies for the treatment of various tumors including renal and breast cancer. Therapies are based upon biologic targets directly connect...

More Information about "WILEX AG" on BioPortfolio

We have published hundreds of WILEX AG news stories on BioPortfolio along with dozens of WILEX AG Clinical Trials and PubMed Articles about WILEX AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of WILEX AG Companies in our database. You can also find out about relevant WILEX AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...


Corporate Database Quicklinks



Searches Linking to this Company Record